Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARVN | GH | CLDX | ||
| Company | Arvinas Inc | Guardant Health Inc | Celldex Therapeutics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 33.12 | 18.59 | 39.76 | ||
| High | 33.15 | 18.67 | 40.99 | ||
| Low | 31.68 | 17.99 | 38.75 | ||
| Last | 32.43 | 18.58 | 40.86 | ||
| Change | -0.05 | +0.32 | +1.51 | ||
| % Change | -0.15% | +1.75% | +3.84% | ||
| Volume | 621,800 | 954,600 | 569,400 | ||
| 20-Day Average Volume | 686,005 | 1,688,810 | 581,525 | ||
| Previous Close | 32.48 | 18.26 | 39.35 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 34.40 | 17.72 | 38.69 | ||
| 20-Day Raw Stochastic | 18.03% | 68.40% | 86.54% | ||
| 20-Day Relative Strength | 34.25% | 50.50% | 53.20% | ||
| Weighted Alpha | -17.32 | -28.67 | +8.59 | ||
| Today's Opinion | 24% Sell | 72% Sell | 48% Buy | ||
| Previous Opinion | 24% Sell | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 40% Buy | 72% Sell | 64% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.63% since 04/25/24 | +8.28% since 04/25/24 | +12.69% since 04/25/24 | ||
| Low | 31.04 on 04/26/24 | 16.77 on 04/26/24 | 35.65 on 04/26/24 | ||
| High | 33.21 on 05/01/24 | 18.97 on 05/01/24 | 40.99 on 05/02/24 | ||
| 1-Month | |||||
| %Chg | -16.93% since 04/02/24 | -10.63% since 04/02/24 | -0.73% since 04/02/24 | ||
| Low | 30.91 on 04/25/24 | 15.81 on 04/19/24 | 35.65 on 04/26/24 | ||
| High | 39.58 on 04/03/24 | 21.68 on 04/03/24 | 41.67 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | -29.45% since 02/02/24 | -16.27% since 02/02/24 | +14.97% since 02/02/24 | ||
| Low | 30.91 on 04/25/24 | 15.81 on 04/19/24 | 35.03 on 02/13/24 | ||
| High | 53.08 on 02/16/24 | 23.36 on 02/12/24 | 53.18 on 03/04/24 | ||
| 6-Month | |||||
| %Chg | +100.06% since 11/02/23 | -30.90% since 11/02/23 | +70.18% since 11/02/23 | ||
| Low | 14.02 on 11/10/23 | 15.81 on 04/19/24 | 24.72 on 11/03/23 | ||
| High | 53.08 on 02/16/24 | 30.36 on 12/14/23 | 53.18 on 03/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,218,644 | 2,222,479 | 2,199,705 | ||
| Shares Outstanding, K | 68,308 | 121,713 | 55,901 | ||
| Annual Sales | 78,500,000 | 563,950,000 | 6,880,000 | ||
| Annual Net Income | -367,300,000 | -479,450,000 | -141,430,000 | ||
| Last Quarter Sales | 34,600,000 | 155,050,000 | 4,130,000 | ||
| Last Quarter Net Income | -64,000,000 | -187,040,000 | -43,310,000 | ||
| 60-Month Beta | 1.95 | 0.92 | 1.60 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.53 on 02/27/24 | -1.58 on 02/22/24 | -0.57 on 02/26/24 | ||
| Latest Earnings Date | 05/03/24 | 05/09/24 | 05/02/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||